James Brian Windsor
Chief Science Officer, TFF Pharmaceuticals, Inc.
Companies
- Rein Therapeutics, Inc.Board member May 13, 2026 to now1
- Rein Therapeutics, Inc.Chief executive officer Dec 4, 2024 to now2
- Rein Therapeutics, Inc.President Nov 21, 2023 to now3
- Rein Therapeutics, Inc.Officer Nov 2, 2023 to now4
- Rein Therapeutics, Inc.Chief operating officer Nov 21, 2023 to Mar 6, 20243
- TFF Pharmaceuticals, Inc.Board member Oct 24, 2019 to Dec 9, 20205
- TFF Pharmaceuticals, Inc.Chief Science Officer Oct 24, 2019 to Dec 9, 20205
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Rein Therapeutics, Inc. RNTX27,271 shares6$17.8K at $0.65Apr 30, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 30, 2026Bought 25,000 shares at $1.00 of Rein Therapeutics, Inc.6
- Dec 5, 2024Bought 161 shares at $2.25 of Rein Therapeutics, Inc.7
- Dec 5, 2024Bought 239 shares at $2.24 of Rein Therapeutics, Inc.7
- Mar 5, 2024Exercised options 2,000 shares of Rein Therapeutics, Inc.8
- Dec 15, 2023Bought 225 shares at $3.37 of Rein Therapeutics, Inc.9
- Nov 20, 2023Bought 5,076 shares at $1.97 of Rein Therapeutics, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARRein Therapeutics, Inc., President
- 4SEC EDGARRein Therapeutics, Inc., Officer
- 5
- 6
- 7SEC EDGARForm 4 filed Dec 9, 2024
- 8SEC EDGARForm 4 filed Mar 6, 2024
- 9SEC EDGARForm 4 filed Dec 18, 2023
- 10SEC EDGARForm 4 filed Nov 21, 2023